Specific combinations of nuclear retinoid receptors acting as ligand-inducible transcription factors mediate the essential role of retinoids in embryonic development. Whereas some data exist on the expression of these receptors during early postimplantation development in mouse, little is known about the enzymes controlling the production of active ligands for the retinoid receptors. Furthermore, at early stages of mouse development virtually no data are available on the presence of endogenous retinoids. In the present study we have used a recently developed high-performance liquid chromatographic (HPLC) technique to identify endogenous retinoids in mouse embryos down to the egg cylinder stage. All-trans-retinoic acid, a ligand for the retinoic acid receptors, was detected in embryos dissected as early as 7.5 dpc (i.e., a combination of midstreak until late allantoic bud stage embryos). At these stages, we detected mRNA coding for all the retinoid receptors, retinoid binding proteins, and two enzymes able to convert retinol to retinal (retinol dehydrogenase 5 (RDH5) and alcohol dehydrogenase 4 (ADH4)). We also detected retinal dehydrogenase type 2 (RALDH2), an enzyme capable of oxidising the final step in the all-trans-retinoic acid synthesis. In egg cylinder stage mouse embryos no all-trans-retinoic acid was detected. However, at this stage its precursor all-trans-retinal was present. In accordance with these HPLC observations, RDH5 and ADH4 were expressed, but no transcripts coding for enzymes that oxidise retinal to retinoic acid. Therefore, our results suggest that RALDH2 is a key regulator in initiating retinoic acid synthesis sometime between the mid-primitive streak stage and the late allantoic bud stage in mouse embryos.
INTRODUCTION
A large number of knockout studies of retinoid (vitamin A) receptors and retinoic acid-synthesising enzymes have demonstrated that retinoids are essential for normal embryonic development (Kastner et al., 1997a,b; Wendling et al., 1999; Niederreither et al., 1999) . However, the exact developmental processes in which retinoids are essential have not been elucidated in detail. This is particularly true for the early postimplantation stages, although data suggest that retinoids may have a function during gastrulation (Ang et al., 1996) .
The different stages of the early postimplantation embryo are defined by the appearance of various markers. The pre-primitive streak stage embryo is often called the egg cylinder stage embryo. This is the predominant embryonic stage when dissecting mouse embryos at 6.5 dpc. At the advanced egg cylinder stage the embryo consists of a dis-tinct embryonic and extraembryonic ectoderm (Fig. 1A) . The primitive streak stages (most prominent at 7.0 -7.75 dpc) include embryos of three stages (Fig. 1B) , the early streak embryo, the midstreak embryo, and the late streak embryo, mainly defined by the length of the primitive streak and the spreading of the mesoderm layer. In late streak embryo, the anterior end of the primitive streak condenses into the "node."
The neural plate stages ( Fig. 1C) (most prominent at 7.5-7.75 dpc) are divided into the no-allantoic-bud stage, early allantoic bud stage, and late allantoic bud stage. In the no-allantoic-bud stage embryo the posterior amniotic fold has fused with the anterior amniotic fold to make the amnion and the head process is visible and there is evidence of neural groove formation. In the late allantoic bud stage embryo the length of the bud is increased and the embryo is becoming wider than it is long. The headfold stage ( Fig. 1D ) (most prominent at 8.0 dpc) is divided into the early headfold stage and the late headfold stage, in which the headfolds are well defined, the neural groove is present in the anterior midline of the embryo, and the foregut pocket is forming just below the headfolds.
Retinoid signalling during embryonic development is dependent on the presence of retinoic acid receptors (RAR) and retinoid X receptors (RXR) and their endogenous ligands (Chambon, 1994; Mangelsdorf and Evans, 1995; . Members of the RAR family are activated by a number of physiologically occurring retinoids, including all-trans-retinoic acid (at-RA), 9-cis-retinoic acid (9c-RA), all-trans-4-oxoretinoic acid, all-trans-4-oxoretinal, all-trans-4-oxoretinol, and all-trans-3,4-didehydroretinoic acid (at-3,4-dd-RA). Members of the RXR family are efficiently activated by 9c-RA, 9-cis-3,4-didehydroretinoic acid, and 9-cis-4-oxoretinoic acid (Chambon, 1994 (Chambon, , 1996 Mangelsdorf and Evans, 1995; . The ligands are usually synthesised in vivo by a complex metabolic system involving numerous enzymes and binding proteins (Blomhoff, 1994) .
The synthesis of at-RA from all-trans-retinol (at-ROH) is a two-step reaction, involving several enzymes. The ratelimiting step in the synthesis of RA is the oxidation of ROH to RAL, in which two classes of enzymes are involved. One class comprises the classical cytosolic medium-chain alcohol dehydrogenases (ADH) (Duester, 1996) and consists of many members, but only the mouse alcohol dehydrogenase class I and class IV genes (ADH1 and ADH4) are good candidates for ROH oxidation. ADH1 and ADH4 are both efficient in the oxidation of at-ROH to at-RAL (Boleda et al., 1993; Han et al., 1998) , while only ADH4 is efficient in the oxidation of 9c-ROH (Allali-Hassani et al., 1998) . Another class comprises the microsomal members of the shortchain alcohol dehydrogenase/reductase superfamily (SDR). Several retinol dehydrogenases of the SDR family are able to oxidise at-ROH but not 9c-ROH (Chai et al., 1995a (Chai et al., ,b, 1996 , whereas some are specific for 9c-ROH and 11c-ROH (Simon et al., 1995; Mertz et al., 1997; Romert et al., 1998) . These latter three enzymes are all homologues (Driessen et al., 1998) called retinol dehydrogenase 5 (RDH5) (Wang et al., 1999) . The relative roles of the different enzymes in ROH oxidation during embryonic development are still unknown.
The final step in the enzymatic generation of RA is the oxidation of RAL to RA. This step can be mediated by two types of enzymes, aldehyde dehydrogenases and xanthine oxidases (XOX) (Ang and Duester, 1999; Zhao et al., 1996; Niederreither et al., 1997; Lee et al., 1991) . The main RA-generating aldehyde dehydrogenases are the retinal dehydrogenase type 2 (RALDH2) and the class 1 aldehyde dehydrogenase (ALDH1), both of which are members of the aldehyde dehydrogenase family.
In tissues retinoids are most often bound to specific proteins. Four cytoplasmic binding proteins specific for retinol and retinoic acid have been identified (Blomhoff et al., 1990) : cellular retinol binding protein (CRBP) types I and II and cellular retinoic acid binding protein (CRABP) types I and II (Wolf, 1991) . All show a high degree of homology (Ong, 1984; Giguere et al., 1990; Chytil and Ong, 1984) and belong to a protein family that also includes protein P2, fatty acid binding protein (Z protein), intestinal fatty acid binding protein, and mammary-derived growth inhibitor (Chytil and Ong, 1984) .
A large number of studies have tested the effects of exogenous retinoids on different vertebrate embryos and suggested possible normal functions of vitamin A (Pijnappel et al., 1993; Wagner et al., 1990; Thaller and Eichele, 1990; Durston et al., 1989; Ruiz and Jessell, 1991) . The validity of these suggestions depends, however, upon whether retinoids are endogenously present in the vertebrate embryo. To confirm the presence of retinoids in embryos, mainly three different approaches have been utilised.
First, high-performance liquid chromatography (HPLC) has been used to chemically identify the various retinoids present. This technique has the potential of unequivocal identification of various retinoids and their absolute amounts. One limitation with HPLC is that when analysing embryos during early postimplantation development the available amount of tissue is often below what is needed to exceed detection limits. Studies of stages preceding neurulation have been done with animal models in which the collection of tissue is not a limiting factor, e.g., zebrafish (Costaridis et al., 1996) and Xenopus (Blumberg et al., 1996; Azuma et al., 1990) . During mouse development no HPLC data are available prior to 9.0 dpc. Horton and Maden (1995) analysed endogenous retinoids in mouse embryos (9 -14 dpc) by HPLC. They detected two retinoids, at-RA and at-ROH, with at-ROH in 5-to 10-fold excess over at-RA. They did not detect 9c-RA or any dd-retinoids.
Second, bioassays have been developed that measure the presence of a substance that is able to enhance expression from a reporter regulated by a RA-response element in F9 reporter cells (Wagner et al., 1992; Maden et al., 1998) . As F9 cells are capable of converting precursors such as ROH and RAL to various ligands for the retinoid receptors, such a bioassay is not designed to identify specific retinoids. Downs and Davies (1993) and Kaufman (1992) . (A) The pre-primitive streak embryo is called the egg cylinder stage. At the advanced egg cylinder stage the embryo consists of a distinct embryonic and extraembryonic ectoderm, the visceral endoderm, and a proamniotic cavity. (B) In the early streak embryo the mesoderm starts to form at the posterior end of the embryonic ectoderm. The mesoderm is visible in a dissecting microscope up to 50% of the length of the posterior side. In midstreak embryos the length of the primitive streak is between 50 and 100% of the length of the posterior side. The mesoderm layer is also spread laterally to the midline. In late streak embryos, the anterior end of the primitive streak condenses into the "node." The posterior amniotic fold is visible. (C) In no-allantoic-bud stage embryos the posterior amniotic fold has fused with the anterior amniotic fold to make the amnion. Two other cavities are also visible, the exocoelomic cavity and the ectoplacental cavity. The head process is visible and there is evidence of neural groove formation in the distal half of the embryonic portion of the egg cylinder. In early allantoic bud embryos, a small allantoic bud is present and the node appears as a "knot" at the distal tip. The head process is still visible and extended anteriorly. In late allantoic bud stage embryos the length of the bud is increased and projected into the exocoelomic cavity. The head process is no longer distinct. An obvious neural groove is visible. The embryo is becoming wider than it is long. (D) In the early headfold stage the allantois is projecting into the exocoelomic cavity. The anterior ectoderm is thickened, and the neural groove is distinct. Late headfold embryos have well-defined headfolds, the neural groove is present in the anterior midline of the embryo, and the foregut pocket is forming just below the headfolds. The node is conspicuous distally.
Examination of mouse embryos by the bioassay suggests that retinoid activity is absent in egg cylinder stage embryos but is present in the late primitive streak stages and onwards (Ang et al., 1996) . Hogan et al. used an alternative "bioassay" (Hogan et al., 1992) . They implanted fragments of mouse embryos into chick wing buds and determined the digit-inducing capacity of the fragments. Hogan et al. (1992) observed that fragments from the egg cylinder stage failed to induce additional digits, while fragments from primitive streak stage embryos and neural plate stage embryos exhibited digit-inducing capacity.
A third strategy that has been used to study retinoid signalling during embryonic development is transgenic mice models containing reporters controlled by retinoidresponsive promoters. Since a more complex promoter, such as the complete RAR␤2 promoter (Mendelsohn et al., 1991; Shen et al., 1992) , might be regulated by a complex combination of transcription factors, the use of a minimal retinoic acid-responsive promoter (Balkan et al., 1992; Rossant et al., 1991) is probably better for studying a retinoid signal. By using such a promoter, Rossant et al. (1991) detected a retinoid signal that appeared in the early headfold stage embryo. In addition, a strong signal was observed in the posterior half of the late headfold stage embryo.
In this study we have used a very sensitive HPLC method to determine retinoids in early mouse postimplantation embryos. Furthermore, by using RT-PCR we have examined the mRNA expression of a number of retinoidmetabolising enzymes, binding proteins, and nuclear receptors in order to detect the factors controlling retinoid signalling in early postimplantation mouse embryos. Our study shows that at-RAL is present in egg cylinder stage mouse embryos. We could not detect any RA in these embryos. Transcripts for two enzymes able to convert ROH to RAL are expressed at this stage, whereas no transcripts coding for enzymes that oxidise RAL to RA were detected. When analysing 7.5-dpc embryos (a combination of embryos from mid-primitive streak (Fig. 1B ) until late allantoic bud stage (Fig. 1C) ), we detected RALDH2 transcripts as well as endogenous at-RA. These data suggest that RALDH2 is a key regulator in initiating a retinoid signal in early postimplantation mouse embryos.
MATERIALS AND METHODS

Chemicals
All-trans-retinoic acid, 9-cis-retinoic acid, 13-cis-retinoic acid, all-trans-retinol, 13-cis-retinol, all-trans-retinal, 13-cis-retinal, and 9-cis-retinal were obtained from Sigma Aldrich. The retinoids 11,13-di-cis-retinol, 9-cis-retinol, all-trans-3,4-didehydroretinal, 9-cis-3,4-didehydroretinal, 9-cis-3,4-didehydroretinoic acid, 9-cis-3,4-didehydroretinol, and all-trans-3,4-didehydro-retinol were gifts from F. Hoffmann La Roche (Basel, Switzerland). All-trans-3,4-didehydroretinoic acid was a generous gift from A. Vahlquist.
Dissection
The study protocol was in accordance with the official governmental guidelines on the care and use of laboratory animals. Female F1 hybrids (C57BL/6J ϫ CBA/J) were superovulated according to Hogan et al. (1994) and the morning of vaginal plug was considered 0.5 dpc. Further staging of mouse embryos was according to Kaufman (1992) and Downs and Davies (1993) (see Fig. 1 ). Pregnant mice were sacrificed by cervical dislocation. Whole embryos were dissected from the decidua, Reichert's membrane, and the ectoplacental cone.
Solid-Phase Extraction-HPLC Electrochemical detection (ECD).
Mouse embryos were analysed for retinoids (Table 1) according to a recently published method (Sakhi et al., 1998) . Briefly, embryos were carefully dissected under red light (Kodak filter No. 25) in cold 0.9% NaCl and immediately frozen in liquid nitrogen and stored at Ϫ70°C until analysis. They were thawed and homogenised with a motorised pellet grinder in a clear Eppendorf tube. Ten microlitres of internal standard were added to 320 l of the homogenate and the volume was adjusted to 340 l with buffer. Then, 510 l of cold acetonitrile was added. After thorough mixing and centrifugation at 5300g for 10 min (5°C), 750 l of the clear supernatant was transferred to an amber glass vial. An aliquot of 250 l of water was added with subsequent mixing, resulting in a final acetonitrile concentration of 45%. The entire procedure was performed under red light and the samples were kept on ice under argon atmosphere whenever possible. An aliquot of 1000 l was then injected onto the HPLC system. The samples were submitted to online solid-phase extraction followed by automated transfer of the extract to the analytical column by column switching. The coulometric electrochemical detection system (ESA, Inc.) consisted of three cells. The guard cell was set to ϩ750 mV and was used to oxidise any trace organic compounds in the separating mobile phase, ensuring a very low background. The screening cell lowered the amount of oxidisable components in the injected sample and was set to ϩ450 mV. The analytical cell was set to ϩ750 mV relative to the palladium reference electrode and provided the signal by oxidising the double bonds in the polyene chain of the retinoid.
Diode array detector (DAD). Mouse embryos (9.5 dpc) were homogenised and 500 l of acetonitrile was added, before mixing and centrifugation. The supernatant was then concentrated and cleaned up on a solid-phase extraction column located in the sample loop. Retinoids retained on the solid-phase extraction column were eluted to analytical column by turning of the valve. After injection of the samples, UV spectra were recorded online with a Shimadzu SPD-M10A diode array detector. The chromatographic conditions were as described by Sakhi et al. (1998) , apart from the flow being 0.5 ml/min, and the analytical column had a 2.1-mm i.d.
Atmospheric pressure electrospray ionization-mass spectrometry (AP-ESI-MS).
Mouse embryos (9.5 dpc) were homogenised and 300 l of acetonitrile was added before mixing and centrifugation. An aliquot of 100 l was injected on a 2.1 ϫ 250-mm suplex pKb-100 column. On-column focusing was performed by conditioning the column with 90% A (acetonitrile:water:acetic acid, 49.5:50:0.5, v/v) and 10% B (acetonitrile:2-propanol:acetic acid, 49.5:50:0.5, v/v) for 1 min and then changing to 20% A and 80% B for the remainder. The flow was 0.350 ml/min. The liquid chromatograph was interfaced with the mass spectrometer by AP-ESI (Hewlett-Packard). The [Mϩ1] ϩ ion of protonated at-RAL was detected in single-ion monitoring mode. The mass-to-charge ratio (m/z) of this ion was 285.4. Tuned to give maximum sensitivity for this fragment, the settings of the mass spectrometer were as follows: fragmentor 50 V, nebuliser pressure 40 psi, drying gas flow 12 L/min, drying gas temperature 300°C, capillary voltage 5000 V, gain 5.
RT-PCR
Mouse embryos were carefully dissected in ice-cold PBS and washed several times in PBS to avoid contamination with maternal tissue. Tissue was frozen in liquid nitrogen and kept at Ϫ70°C until analysis. mRNA was isolated from a pool of embryos using a MicroFast mRNA isolation kit (Invitrogen). cDNA synthesis and PCR amplifications (40 cycles) were performed as described . The specific oligonucleotides are shown in Table 2 . Each RT-PCR analysis was carried out using a negative control, either without reverse transcriptase or by replacing the mRNA template with water when PCR products spanned an intron. Each positive result was repeated at least two times (and each negative result was repeated five times). The identity of all PCR products was confirmed by sequencing (MediGenomix). ␤-Actin was used in all experiments as a positive control to ensure the quality of mRNA.
RESULTS AND DISCUSSION
Endogenous Retinoids in 6.5-to 9.5-dpc Mouse Embryos
No data exist on endogenous retinoids in mouse embryos at stages earlier than 9.0 dpc (Horton and Maden, 1995) . In order to measure retinoids during early postimplantation stages in mouse embryos, we used a highly sensitive HPLC method. To preserve the configuration of the extremely labile retinoids, online solid-phase extraction, microcolumns, and column switching and DAD, coulometric ECD, or mass spectrometry were employed. The method applied in this study has been fully validated and shows excellent precision and reproducibility (Sakhi et al., 1998) . The limit of detection is 27 fmol for at-RA, 70 fmol for at-ROH, and 165 fmol for at-RAL compared to about 30 pmol for the method used previously for mouse embryo analyses (Horton and Maden, 1995) . This method was used to screen mouse embryos at different stages of development (6.5-9.5 dpc) for 16 different retinoids (Table 1 , Fig. 2A) .
In initial experiments, 9.5-dpc embryos were collected and prepared for analysis and a volume equivalent to 1.6 embryos was injected into the HPLC system equipped with the coulometric EC detector. The amounts of at-ROH and at-RA were 970 and 250 fmol per embryo, respectively (Fig.  2B) . The other retinoids were either absent or below the detection limit. When analysing 8.5-dpc mouse embryos (i.e., 8 -12 somites) a homogenate equivalent to 9 embryos was used (Fig. 3) . In such embryos, we detected 87 and 13 fmol at-ROH and at-RA, respectively, per embryo. We then analysed embryos collected at 7.5 dpc (i.e., a combination of embryos from mid-primitive streak until late allantoic bud stage). In such embryos we detected 32, 28, and 2.0 fmol at-ROH, at-RAL, and at-RA, respectively, per embryo (Fig.  3) . When analysing embryos dissected at 6.5 dpc (i.e., egg cylinder stage embryos) we were not able to detected either at-ROH or at-RA, only at-RAL (20 fmol per embryo) (Fig. 3) .
When using HPLC systems with coulometric EC detectors (as above) or single-wavelength UV detectors, identity of any compound is based on coelution with authentic standards. We therefore confirmed the identity of at-ROH and at-RA by online recording of UV spectra of the endogenous compounds from 20 9.5-dpc embryos (Fig. 2C) . In this experiment, a peak coeluting with at-RAL was also seen, but the mass of this substance was insufficient to provide an adequate UV spectrum. However, by using LC-MS we demonstrated that the identity of the peak was at-RAL (Fig.  4) . The amount of at-RAL detected by the MS detector was 109 fmol/embryo.
Thus, these data demonstrate surprisingly that at-RAL is the predominant retinoid in egg cylinder stage embryos and that a detectable level of at-RA first appears sometime between the mid-primitive streak stage and the late allantoic bud stage. We were not able to detect any other known ligands for the RAR and RXR subtypes at these stages, including 9c-RA (Fig. 3) . The absence of endogenous 9c-RA in the embryo in the present study in which we have used ultrasensitive HPLC analysis is noteworthy and adds to previous attempts to identify 9c-RA in mouse embryos (Horton and Maden, 1995) .
Our results are in agreement with the bioassay data reported by Hogan et al. (1992) and Ang et al. (1996) . In reporter mice, retinoid signalling is first detected in early headfold stage embryos (Rossant et al., 1991; Balkan et al., 1992) . Thus, these studies collectively suggest that at-RA first accumulates at detectable levels during the primitive streak stages.
It has been suggested that the metabolism and activation 
Retinoid isomer Abbreviation
All-trans-retinol at-ROH 13-cis-retinol 13c-ROH 11,13-di-cis-retinol 11c, 13c-ROH 9-cis-retinol 9c-ROH All-trans-3,4-didehydroretinol at-dd-ROH 9-cis-3,4-didehydroretinol 9c-dd-ROH All-trans-retinal at-RAL 13-cis-retinal 13c-RAL 9-cis-retinal 9c-RAL All-trans-3,4-didehydroretinal at-dd-RAL 9-cis-3,4-didehydroretinal 9c-dd-RAL All-trans-retinoic acid at-RA 13-cis-retinoic acid 13c-RA 9-cis-retinoic acid 9c-RA All-trans-3,4-didehydroretinoic acid at-dd-RA 9-cis-3,4-didehydroretinoic acid 9c-dd-RA of retinoids during early embryonic development are fundamentally different in embryos of lower vertebrates such as Xenopus and zebrafish compared to higher vertebrates such as mouse and human. Lower vertebrates store large amounts of RAL, while indirect evidence has pointed towards ROH as the storage form in higher vertebrates (Costaridis et al., 1996; Horton and Maden, 1995) . Our data demonstrate, however, that RAL is the predominant retin- oid in egg cylinder stage mouse embryos. This RAL might be a result of embryonic uptake of retinoids from the mother, e.g., as maternal retinol-RBP (Båvik et al., 1996) . Alternatively, at-RAL is derived from retinoids or carotenoids stored in the preimplanted embryo. The observations that egg cylinder stage embryos contain at-RAL and express the enzyme ADH4 (see below) may seem to favour the former mechanism. If so, the embryo may first take up at-ROH followed by a subsequent expression of ADH4, which then converts at-ROH into at-RAL that accumulates in egg cylinder stage embryos.
Expression of Retinoid Metabolising Enzymes in 6.5-to 9.5-dpc Mouse Embryos
By using a sensitive RT-PCR technique we screened the embryos (6.5-9.5 dpc) for transcripts coding for a number of enzymes, binding proteins, nuclear receptors, and repressors known to be involved in retinoid signalling. We were first interested in the expression pattern of the different transcripts involved in the metabolism and function of vitamin A in whole embryos at early stages, for which little or no information is available. Embryos were analysed for transcripts coding for enzymes able to oxidise retinol to (1) at-3,4-dd-RAL, (2) at-3,4-dd-ROH, (3) 13c-RAL, (4) at-RAL, (5) at-ROH, (6) at-3,4-dd-RA, (7) 9c-RA, (8) at-RA. The background has been digitally subtracted. (B) The thick line represents the elution profile showing substances oxidisable at ϩ750 mV versus the palladium reference electrode in 9.5-dpc mouse embryos. The internal standard 13-cisacitretin is labelled i.s. The peak labelled 1 coeluted with at-ROH, indicated with white arrow. The peak labelled 2 coeluted with at-RA, indicated with black arrow. The thin line represents the control sample that followed the real sample from collection to analysis. (C) Analysis of the same sample as in B using a DAD. Full spectral data were recorded online in the range 250 -450 nm. The recorded spectrum of peak 1 is shown in the inset superimposed on the spectrum from pure authentic at-ROH standard. In a similar manner the spectrum of peak 2 is shown. The minor peak eluting in front of peak 1 has the same retention time as at-RAL, but the absorption of this peak was not sufficient for adequate UV spectrum to be recorded. Peaks were also confirmed by spiking of the samples with retinoid standards. retinal (ADH1, ADH4, RoDH1, RoDH3, RDH5, CRAD1, and CRAD2) and further to retinoic acid (ALDH1, RALDH2, and XOX) (Figs. 5A and 5B). In egg cylinder stage embryos (6.5 dpc), we detected ADH4 and RDH5 mRNA, two enzymes catalysing oxidation of ROH to RAL. These enzymes were also expressed at all later stages studied. Of the other enzymes catalysing oxidation of ROH to RAL, CRAD1 and ADH1 were first expressed in 9.5-dpc embryos, while RoDH1, RoDH3, and CRAD2 mRNAs were not expressed in any of the stages tested (Fig. 5A) . Expression of ADH1 in 9.5-dpc embryos is in agreement with the in situ hybridisation data from Ang et al. (1996) . They observed that ADH1 expression at this stage was limited to the mesonephros, a structure that gives rise to portions of the genitourinary system. This indicates that the main RALsynthesising enzymes during early postimplantation embryos are ADH4 and RDH5, while ADH1 and CRAD1 may contribute to RAL synthesis in 9.5-dpc embryos.
We detected no transcripts coding for enzymes oxidising RAL to retinoic acid in egg cylinder stage embryos (6.5 dpc) (Fig. 5B) . These data are in accordance with our HPLC analysis in which we identified at-RAL but not at-RA in such embryos. In 7.5-dpc embryos (mainly mid-primitive streak stage until no-allantoic-bud stage embryos), however, we detected RALDH2 mRNA, an enzyme capable of oxidising the at-RAL into the active ligand at-RA. Thus, these results suggest that RALDH2 is a key enzyme involved in initiating RA synthesis in early postimplantation mouse embryos. Our results also suggest that several alternative pathways exist for at-RA production during later stages of development as ALDH1 mRNA appeared in 8.5-dpc mouse embryos and XOX mRNA in 9.5-dpc embryos (Fig. 5B) .
These data greatly extend our knowledge of the expression of enzymes involved in RA synthesis during early postimplantation development. By using in situ hybridisation, Ang et al. (1996) previously detected ADH4 mRNA in 7.0-to 7.5-dpc mouse embryos in the posterior region of the embryo along the primitive streak. We used the more sensitive RT-PCR technique and demonstrated that ADH4 is expressed also at the egg cylinder stage. The other enzyme that we observed in egg cylinder stage embryos was RDH5. The expression of this enzyme has not been studied in 6.5-and 7.5-dpc embryos before, but was detected in neuroepithelium in 8.5-dpc embryos (Romert et al., 1998) . Since we now demonstrate that ADH4 as well as RDH5 is expressed in egg cylinder stage embryos, two alternative pathways may exist for retinal synthesis at this stage. This is in accordance with the observation that ADH4 Ϫ/Ϫ mutant mice, who most likely have a normal expression of RDH5, have normal survival rates compared to wild-type except when challenged by vitamin A deficiency (Deltour et al., 1999) . CRAD1 (Chai et al., 1997) and CRAD2 (Su et al., 1998) mRNAs have not been studied previously in embryonic tissues. Since CRAD2 mRNA was not detected and CRAD1 mRNA is detected only in 9.5-dpc embryos, these enzymes, which are most effective with cis isomers of ROH, do not seem to have any function in RA synthesis during early postimplantation stages in mice. The same is true for RoDH1 and RoDH3, whose transcripts were not detected at any of the stages analysed. Previously, these two enzymes have been detected only in liver (Chai et al., 1995b (Chai et al., , 1996 , an organ not completely developed in 9.5-dpc embryos.
We detected RALDH2 mRNA in 7.5-dpc but not in 6.5-dpc embryos. Lack of RALDH2 expression in 6.5-dpc embryos is in accordance with an in situ hybridisation study by Niederreither et al. (1997) . They detected RALDH2 expressed in the posterior half of the early allantoic and late allantoic bud stage embryo, in mesoderm adjacent to the node and on each side of the primitive streak and in individual cells in the primitive streak. By using in situ hybridisation Ang et al. (1996) observed that ALDH1 was expressed in the posterior half of the embryo in 7.5-dpc embryos, but not in 6.5-dpc embryos. We could not detect any ALDH1 expression in either 6.5-or 7.5-dpc embryos. As XOX (dehydrogenase form), which has been suggested to be an alternative retinal dehydrogenase (Lee et al., 1991) , is expressed in 9.5-dpc embryos but not in 6.5-to 8.5-dpc embryos, this enzyme also seems not to have a role in retinoid metabolism during early postimplantation stages of development.
All the Cellular Retinoid Binding Proteins Are Expressed in 6.5-to 9.5-dpc Mouse Embryos
Studies on the distribution of the various types of CRBPs and CRABPs have established that CRBPI and CRABPI are the predominant intracellular retinoid binding proteins in most tissues. Several lines of evidence indicate that the intracellular binding proteins protect their ligands from nonspecific reactions with several enzymes, but permit metabolism with other more specific enzymes. For example, it has been hypothesised that activation of ROH to RA is controlled, in part, by the relative amounts of apoCRBPI and holoCRBPI (Napoli, 1996) . Although the cellular retinoid binding proteins are not known as essential for retinoid function, they have been shown to modulate the metabolism of retinoids. For example, by inactivation of the CRBPI gene in mice, it was recently demonstrated (Ghyselinck et al., 1999) that its absence results in a waste of ROH that is asymptomatic in vitamin A-sufficient animals, but leads to a severe syndrome of vitamin A deficiency in animals fed a diet containing low amounts of vitamin A. We observed expression of transcripts for the cellular binding proteins CRBPI, CRBPII, CRABPI, and CRABPII at all stages analysed, including the egg cylinder stage (Fig. 5C ).
In previous reports in which the expression patterns of cellular retinoid binding proteins were studied from 7.5 dpc by in situ hybridisation (Ruberte et al., , 1992 , CRABPI and CRBPI expression was detected in 7.5-dpc embryos. CRBPI expression was highest in both epiblast and primary mesenchyme of the primitive streak. CRABPI expression was observed in the primary mesenchyme, including the allantois, overlapping with CRBPI expression just lateral to the primitive streak, but not in the streak itself. CRABPI and II also seem to have individual functions during early embryonic development since they are localised in different parts of the 8.0-dpc embryo (Ruberte et al., 1992) .
Since CRBPII is almost exclusively expressed in the small intestine in adults, the protein is often regarded as a specific binding protein, which functions only in intestinal absorption of retinol. Previous studies have, however, demonstrated high expression of CRBPII in some other tissues, including the liver, during late embryonic stages (Levin et al., 1987) . Our present demonstration of an expression of CRBPII from the egg cylinder stage and onwards suggests that CRBPII also is involved in retinoid metabolism in some very early stages of development.
Expression of Nuclear Receptors and Corepressors
When we analysed for transcripts coding for the nuclear retinoid receptors we observed that all the RARs (RAR␣, ␤, ␥) and all the RXRs (RXR␣, ␤, ␥) were expressed in 6.5-, 7.5-, and 8.5-as well as 9.5-dpc embryos (Fig. 5D) . The expression of RXR subtypes before 8.5 dpc has not been studied previously (Dolle et al., 1994) . Since we observe RXR expression in both 6.5-and 7.5-dpc embryos, our results suggest that RXR can function as either a homodimer or a heterodimer partner for RAR or other members of the superfamily of ligand-inducible transcription factors at least down to the egg cylinder stage. Our results confirm the previous observations (Ruberte et al., 1990 Dolle et al., 1994; Ang and Duester, 1997 ) that RAR␣ and RAR␥ are expressed as early as 6.5 dpc. However, our results extend previous knowledge as we also demonstrate that RAR␤ is expressed in the egg cylinder stage embryo and that the RAR␣2, RAR␤2, and RAR␥2 isoforms are expressed in such embryos. Interestingly, all these three isoforms have a retinoic acid-response element in their promotor . Thus, our data, which are in agreement with previous suggestions (Ang and Duester, 1997) , demonstrate that induction of the expression of these receptors does not seem to control the initiation of retinoid signalling during primitive streak formation, since all the retinoid receptors are expressed at the egg cylinder stage and onwards.
Chicken ovalbumin upstream promoter transcription factor (COUP-TF) types I and II belong to the superfamily of ligand-inducible transcription factors and are known to efficiently repress transcription driven by RAR-RXR heterodimers (Chambon, 1996; . Further, we demonstrate that the COUP-TF I and II are expressed at all stages from 6.5 to 9.5 dpc in mouse embryos (Fig. 5E ). These receptors have previously been studied by Qiu and co-workers (Qiu et al., 1994) from 7.5 dpc using in situ hybridisation, but they could not observe any staining 388 Ulven et al. before 8.5 dpc. Although further experiments are needed to investigate whether COUP-TF I and II are present in the same cells as the retinoid receptors, these orphan receptors are potential modulators of retinoid signalling in early stages of development.
The mechanism of action of retinoids in gene expression has been shown to involve a balance between coactivators with histone acetylase activity and corepressors with histone deacetylase activity. The expression of the most prominent coactivator, CBP/p300, has previously been demonstrated at 7.5 dpc of mouse development (Yao et al., 1998) . Here, we demonstrate that the most prominent nuclear corepressor, N-CoR, is expressed in 7.5-dpc embryos and later stages but not in 6.5-dpc embryos (Fig. 5E) . Together, these data suggest that a functional corepressor/ coactivator mechanism is present in 7.5-dpc embryos when retinoid signalling first seems to appear.
In summary, the present study shows that mRNA transcripts for all the RAR and RXR subtypes, two ROH oxidising enzymes, and all the binding proteins are expressed in egg cylinder stage embryos, with the important exception of enzymes able to convert RAL to RA (Fig. 6) . Expression of RALDH2 mRNA in 7.5-dpc embryos suggests that these embryos, sometime between the mid-primitive streak stage and the late allantoic bud stage (Fig. 1) , are able to perform the last step in RA synthesis. Recently, Niederreither and co-workers (1999) generated a targeted disruption of the mouse RALDH2 gene and found that RALDH2 Ϫ/Ϫ embryos, which die at midgestation without undergoing axial rotation, exhibit shortening along the anterioposterior axis, heart, and frontonasal malformation and do not form limb buds. Furthermore, these defects result from a block in embryonic retinoic acid synthesis, as shown by the lack of activity of RA-responsive transgenes, the altered expression of an RA-target homeobox gene, and the near full rescue of the mutant phenotype by maternal RA administration. These results are fully in accordance with our results and interpretations, i.e., an essential role of RALDH2 in the regulation of RA synthesis during early postimplantation stages. We have also used sensitive HPLC techniques to identify the precursor, at-RAL, in egg cylinder stage mouse embryos, and the active ligand, at-RA, in 7.5-dpc mouse embryos. These embryos represent a combination of embryos from mid-primitive streak until late allantoic bud stage. No other retinoid ligands, including 9c-RA, were detected in preneurulation stage mouse embryos, suggesting that retinoid signalling in early embryos does not require anything other than at-RA. Expression of two alternative enzymes (ADH4 and RDH5) capable of synthesising RAL is detected in egg cylinder stage embryos. Since RDH5 is most active in the conversion of c-ROHs, while ADH4 efficiently converts at-ROH into at-RAL, the data suggest that ADH4 is crucial for retinoid signalling in egg cylinder stage embryos. Additionally we detected mRNA coding for an enzyme capable of oxidising the final step in the at-RA synthesis (i.e., RALDH2) in mouse embryos dissected at 7.5 dpc (Fig. 6) . Therefore, our results suggest that RALDH2 is the key regulator in retinoid signalling in early postimplantation mouse embryos.
